Author's posts
Building Bridges Between Data Silos: Mayo Clinic Platform’s Ambitious Endeavor To Enable A Learning Healthcare System
“I’ve been working for 40 years to get to this point,” says Halamka, who is excited and optimistic about seeing the technology he always envisioned become real. “I don’t want to leave this to the next generation to solve.”
Is A Downturn The Best Time To Invest In Marketplaces And Platforms In Healthcare?
For founders and investors focused on building marketplaces and platforms in digital health, 2023 may be the time to heed Buffett’s counsel: when everybody around seems fearful and focused on playing it safe, it just may be the right time to be audacio…
Under Financial Pressure, How Are Health Systems Prioritizing Digital Health Investments?
The current economic climate, rising costs and interest rates, and planned cuts to Medicare payments are all impacting organizations’ financial outlooks – issues only compounded by having to take care of sicker patients, while dealing with the fallout …
Crescendo Health’s Funding Signals Growing Momentum For The Role Platforms Can Play In Clinical Trials Innovation
Increasing access to clinical trials – for both patients as well as research sites – is critical as issues like clinical trial diversity, health equity and acceptance of RWD become more highly visible and important.
Crescendo Health aims to do that by…
The Anti-Prediction Article: What Won’t Change In Healthcare In 2023?
Change in healthcare tends to occur one step at a time. Understanding what won’t happen in the short term can be even more critical to strategic and investment decisions than predicting long term trends.
To that end, here are some experts’ “anti-pred…
Big Techies: Healthcare Is Waiting With Open Arms
As the landslide of layoffs continues in big tech, workers can find opportunity, purpose and incredible skills-alignment in healthcare.
Does Ethical AI Development Rely On The “Algorithmically” Underserved? CHAI’s Mission
Building this kind of standardization into the relatively black box nature of AI development is among the priorities of The Coalition for Health AI (CHAI), which launched earlier this year.
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 1)
The question “Do PBMs add value or abuse their position?”, misses the point. The better question is: Is there a better model than the current PBM model?”
PBMs need to consider that when your house is on fire, you don’t worry about the knicknacks insid…
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 2)
Smart companies are embracing network effects and platform business strategies for a reason: they grow faster, scale more efficiently, are more profitable, and see higher valuations by investors. Platforms also now dominate formerly plodding industries…
Flight Of The Healthcare Navigators: Why Glen Tullman’s Best Magic Trick Yet May Be Buying Teladoc
For Transcarent CEO Glen Tullman, there is a strong case to buy telehealth behemoth Teladoc – the very company that acquired Tullman’s last company, Livongo for $18.5 billion. Tullman could buy back the entirety of Teladoc for less than a quarter of wh…
